Jundishapur Journal of Chronic Disease Care

Published by: Kowsar

Psychometric Properties of the Medication Non-Adherence Questionnaire in Patients With Psychiatric Disorders

Masoud Bahreini 1 , Zahra Rafiee 2 , * , Shahnaz Pouladi 1 , Kamran Mirzaei 3 and Masoud Mohammadi Baghmollaei 4
Authors Information
1 Department of Nursing, Bushehr University of Medical Sciences, Bushehr, IR Iran
2 Student Research Committee, Department of Nursing, Bushehr University of Medical Sciences, Bushehr, IR Iran
3 Department of Social Medicine, Bushehr University of Medical Sciences, Bushehr, IR Iran
4 Health School, Bushehr University of Medical Sciences, Bushehr, IR Iran
Article information
  • Jundishapur Journal of Chronic Disease Care: July 01, 2015, 4 (3); e27062
  • Published Online: July 25, 2015
  • Article Type: Research Article
  • Received: January 17, 2015
  • Revised: April 16, 2015
  • Accepted: May 4, 2015
  • DOI: 10.5812/jjcdc.27062v2

To Cite: Bahreini M, Rafiee Z, Pouladi S, Mirzaei K, Mohammadi Baghmollaei M. Psychometric Properties of the Medication Non-Adherence Questionnaire in Patients With Psychiatric Disorders, Jundishapur J Chronic Dis Care. 2015 ; 4(3):e27062. doi: 10.5812/jjcdc.27062v2.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001; 26(5): 331-42[PubMed]
  • 2. Priebe S, Yeeles K, Bremner S, Lauber C, Eldridge S, Ashby D, et al. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial. BMJ. 2013; 347[DOI][PubMed]
  • 3. Staring AB, Mulder CL, Duivenvoorden HJ, De Haan L, Van der Gaag M. Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life. Schizophr Res. 2009; 113(1): 27-33[DOI][PubMed]
  • 4. Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: making it simple. MedGenMed. 2005; 7(1): 4[PubMed]
  • 5. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull. 1995; 21(3): 419-29[PubMed]
  • 6. Stewart SL, Baiden P. An exploratory study of the factors associated with medication nonadherence among youth in adult mental health facilities in Ontario, Canada. Psychiatry Res. 2013; 207(3): 212-7[DOI][PubMed]
  • 7. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research. 2000; 42(3): 241-7[DOI]
  • 8. George J, Mackinnon A, Kong DC, Stewart K. Development and validation of the Beliefs and Behaviour Questionnaire (BBQ). Patient Educ Couns. 2006; 64(1-3): 50-60[DOI][PubMed]
  • 9. Omranifard V, Yazdani M, Yaghoubi M, Namdari M. Noncompliance and its causes resulting in psychiatric readmissions. Iran J of Psychiatry. 2008; 3(1): 37-42
  • 10. van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007; 7: 55[DOI][PubMed]
  • 11. Ghaffari-Nejad A, Mashayekhi A, Mazhari S, Ghayoumi A. Factors Associated With Drug Non-Adherence After Discharge Among Patients With Mood Disorders Hospitalized in Shahid Beheshti Hospital in Kerman: A Prospective Study. Substance abuse. 2015; 57: 38
  • 12. Mitchell AJ, Selmes T. Why don't patients take their medicine? Reasons and solutions in psychiatry. Advances in Psychiatric Treatment. 2007; 13(5): 336-46[DOI]
  • 13. Mahtani KR, Heneghan CJ, Glasziou PP, Perera R, Mahtani KR. Reminder packaging for improving adherence to self-administered long-term medications. Cochrane Database Syst Rev. 2011; 9(9)[DOI]
  • 14. Abu Rahma HM. Drug compliance and family support contribute in preventing relapse among schizophrenia clients in Gaza strip. Islamic university of Gaza Univ. 2014;
  • 15. Westen D, Rosenthal R. Quantifying construct validity: two simple measures. J Pers Soc Psychol. 2003; 84(3): 608-18[PubMed]
  • 16. Thompson B. Exploratory and confirmatory factor analysis: Understanding concepts and applications. 2004; [DOI]
  • 17. Pirasteh A, Hidarnia A, Asghari A, Faghihzadeh S, Ghofranipour F. Development and validation of psychosocial determinants measures of physical activity among Iranian adolescent girls. BMC Public Health. 2008; 8: 150[DOI][PubMed]
  • 18. Lacasse Y, Godbout C, Series F. Health-related quality of life in obstructive sleep apnoea. Eur Respir J. 2002; 19(3): 499-503[PubMed]
  • 19. Gabriel A, Violato C. Knowledge of and attitudes towards depression and adherence to treatment: the Antidepressant Adherence Scale (AAS). J Affect Disord. 2010; 126(3): 388-94[DOI][PubMed]
  • 20. Minaiyan M, Taheri M, Mirmoghtadaee P, Marasi M. Comparative Role of Demographic Factors and Patient's Belief about Prescribed Medicine on Adherence to Drug Treatment in Chronic Diseases. Journal of Isfahan Medical School. 2011; 29(156)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments